Skip to main content
. 2021 Oct 26;13(11):1779. doi: 10.3390/pharmaceutics13111779
AD Alzheimer’s Disease
ALS Amielotropic Lateral Sclerosis
BBB Blood-Brain Barrier
BMECs Human Brain Microvascular Endothelial Cells
CLN-5 Claudin-5
CNS Central Nervous System
GLUT-1 Glucose Transporter
HDAC Histone Deacetylases
HDAC i HDAC inhibitor
HIV Human Immunodeficiency Virus
ICAM1 Intercellular Adhesion Molecule 1
MLC Myosin Light Chain
MMPs Matrix Metalloproteases
MRP Multidrug Resistance-Associated Protein
MS Multiple Sclerosis
NOX NADPH Oxidase
Nrf2 Nuclear Factor Erythroid 2 (NFE2)-Related factor 2)
NVU Neurovascular Unit
OCLN Occludin
PD Parkinson’s Disease
P-gp P-glycoprotein
VEGF Vascular Endothelial Growth Factor
ROCK RhoA/Rho-Associated Proteins Kinase
ROS Reactive Oxygen Species
VCAM1 Vascular Cell Adhesion Protein 1
VEGFR2 Vascular Endothelial Growth Factor Receptor-2
TJs Tight Junctions
ZO-1 Zona Occludens-1
3D 3 Dimensional